Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites

Table 1 Patient characteristics for 10 patients who received EPVS

No.	age	sex	primary disease	nature of ascites	PS	indication for EPVS	EPVS duration, days	survival duration, days	outcome	AEs
1	22	F	synovial sarcoma	serous	3	poor PS	6	6	not effective	renal failure**
2	64	M	mesothelioma	serous	1	potential PVS dysfunction	3	133	effective*	none
3	46	M	lymphoma	serous	4	anasarca, poor PS	14	23	effective*	pulmonary edema**, diarrhea
4	62	F	ovary cancer	bloody	1	history of PVS occlusion	4	200	effective*	none
5	49	F	colon cancer	bloody	1	anasarca, potential PVS dysfunction	4	77	effective*	none
6	57	F	mesothelioma	serous	1	potential PVS dysfunction	16	133	effective*	none
7	56	F	breast cancer	chylous	1	potential PVS dysfunction	3	114	effective*	none
8	48	F	lung cancer	chylous	1	anasarca, history of PVS occlusion	28	28	effective	diarrhea, anemia
9	50	F	cholangiocarcinoma	chylous	4	anasarca, poor PS	24	24	effective	diarrhea
10	69	M	chondrosarcoma	serous	4	poor PS	2	2	not effective	renal failure**
median	52.3						10.4	74.0

ISSN: 1477-7819